{"gene":"SMAD6","run_date":"2026-04-28T20:42:08","timeline":{"discoveries":[{"year":1997,"finding":"Smad6 forms stable associations with TGF-β superfamily type I receptors, interferes with phosphorylation of Smad2 by the TGF-β type I receptor, blocks subsequent Smad2-Smad4 heteromerization, and inhibits phosphorylation of Smad1 induced by the BMP type IB receptor, acting as an inhibitory Smad.","method":"Co-immunoprecipitation, phosphorylation assays, transfection-based signaling assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — foundational paper with multiple orthogonal methods, >874 citations, replicated by subsequent studies","pmids":["9335505"],"is_preprint":false},{"year":1998,"finding":"Smad6 specifically competes with Smad4 for binding to receptor-activated (phosphorylated) Smad1, yielding an apparently inactive Smad1-Smad6 complex, thereby acting as a Smad4 decoy to selectively antagonize BMP/Smad1 signaling without interfering with receptor-mediated phosphorylation of Smad1.","method":"Co-immunoprecipitation, Xenopus embryo overexpression assays, mammalian cell transfection, transcriptional reporter assays","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods in two model systems, >579 citations, replicated across labs","pmids":["9436979"],"is_preprint":false},{"year":2007,"finding":"Smad6 selectively inhibits BMP signaling from the ALK-3/6 subgroup of BMP type I receptors in preference to the ALK-1/2 subgroup; specific amino acid residues (Arg-238, Phe-264, Thr-265, Ala-269) in the N-terminal lobe of the ALK-3 kinase domain determine Smad6 sensitivity, and direct interaction with type I receptors is a critical step in Smad6 function.","method":"Transcriptional reporter assays, mutagenesis of receptor residues, co-immunoprecipitation","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis combined with binding and functional assays in multiple cell types","pmids":["17493940"],"is_preprint":false},{"year":2000,"finding":"Smad6 interacts with the homeobox transcription factor Hoxc-8 as a transcriptional corepressor in the nucleus; the Smad6-Hoxc-8 heterodimer binds DNA (including Hoxa-9 sites) and inhibits Smad1 interaction with Hoxc-8 and Smad1-induced transcriptional activity, providing a nuclear mechanism of BMP signal inhibition.","method":"Yeast two-hybrid, co-immunoprecipitation, gel-shift (EMSA) assays, luciferase reporter assays","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (Y2H, Co-IP, EMSA, reporter), strong mechanistic follow-up","pmids":["10722652"],"is_preprint":false},{"year":2000,"finding":"Smad6 knockout mice display cardiac valve hyperplasia, outflow tract septation defects, aortic ossification, and elevated blood pressure, demonstrating an essential in vivo role for Smad6 in cardiovascular development and homeostasis through modulation of TGF-β superfamily signaling.","method":"Targeted gene disruption (knockout mouse), LacZ reporter knock-in for expression mapping, histological and physiological analyses","journal":"Nature Genetics","confidence":"High","confidence_rationale":"Tier 2 — clean in vivo KO with specific cardiovascular phenotypic readouts, >388 citations","pmids":["10655064"],"is_preprint":false},{"year":2000,"finding":"BMP2-induced apoptosis is mediated through activation of TAK1 and subsequent p38 phosphorylation; Smad6 blocks this pathway by directly binding to TAK1, preventing TAK1 activation and p38 phosphorylation, demonstrating a non-Smad inhibitory mechanism.","method":"Kinase-negative TAK1 expression, co-immunoprecipitation of Smad6-TAK1, apoptosis assays, Western blot for p38 phosphorylation","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — direct binding shown by Co-IP, functional rescue with kinase-dead TAK1, multiple readouts","pmids":["10748100"],"is_preprint":false},{"year":2000,"finding":"The mouse Smad6 promoter contains a proximal BMP-responsive element (PBE) with a GC-rich GCCGnCGC-like motif that is directly bound by BMP-activated Smad1/5 and Smad4, driving Smad6 transcription as a negative feedback loop.","method":"Promoter deletion analysis, luciferase reporter assays, gel-shift (EMSA) for direct DNA binding by Smad1/5 and Smad4","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — direct DNA binding demonstrated by EMSA plus functional promoter dissection","pmids":["10692396"],"is_preprint":false},{"year":2003,"finding":"Smad6 recruits transcriptional corepressor CtBP via a consensus PLDLS motif in its linker region to repress BMP-induced Id1 transcription; mutation of the PLDLS motif abolishes CtBP binding and the repressor activity of Smad6.","method":"Co-immunoprecipitation, mutagenesis of the PLDLS motif, luciferase reporter assays","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis combined with binding assays and transcriptional readout","pmids":["14645520"],"is_preprint":false},{"year":2005,"finding":"Smad6 interacts with Runx2 (but not Smad7) and mediates Smurf1-induced ubiquitin-proteasome-dependent degradation of Runx2, serving as a scaffold between Smurf1 and Runx2 in a Smad6-dependent manner.","method":"Co-immunoprecipitation, ubiquitin-proteasome degradation assays with proteasome inhibitors, deletion mutant analysis","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus functional ubiquitination/degradation assays with mechanistic controls","pmids":["16299379"],"is_preprint":false},{"year":2005,"finding":"Smad6 interacts with the N-terminal domain of the glucocorticoid receptor (GR) through its MH2 domain and suppresses GR-mediated transcriptional activity by recruiting histone deacetylase 3 (HDAC3) to DNA-bound GR, antagonizing histone H3/H4 acetylation induced by p160 coactivators.","method":"Co-immunoprecipitation, adenovirus-mediated overexpression in vivo (rat liver), chromatin acetylation assays, luciferase reporter assays","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple methods including in vivo delivery and mechanistic dissection of HDAC3 recruitment","pmids":["16249187"],"is_preprint":false},{"year":2006,"finding":"Smad6 binds to Pellino-1 (an adaptor protein of IRAK1) via its MH2 domain, abrogating IRAK1-Pellino-1-TRAF6 complex formation after IL-1β stimulation, thereby preventing IκBα degradation, NF-κB nuclear translocation, and pro-inflammatory gene expression as part of TGF-β/BMP anti-inflammatory signaling.","method":"Co-immunoprecipitation, siRNA knockdown, NF-κB reporter assays, gene expression analysis","journal":"Nature Immunology","confidence":"High","confidence_rationale":"Tier 2 — direct binding shown, functional rescue by knockdown, mechanistic pathway placement with multiple readouts","pmids":["16951688"],"is_preprint":false},{"year":2006,"finding":"Smad6 is phosphorylated at a serine residue by protein kinase X (PrKX); during macrophage differentiation of HL-60 cells, Smad6 co-localizes with PrKX in the nucleus and shows increased serine phosphorylation, correlating with increased Smad6 binding to osteopontin, Id2, and Hex gene promoters.","method":"Yeast two-hybrid, co-immunoprecipitation, in vitro phosphorylation assay, mutagenesis, EMSA, chromatin immunoprecipitation (ChIP), siRNA knockdown","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro kinase assay with mutagenesis, ChIP, and functional differentiation readout","pmids":["16491121"],"is_preprint":false},{"year":2006,"finding":"PRMT1 methylates Smad6 (and Smad7) but not R-Smads or Smad4; PRMT1 interacts with the N-terminal domain of Smad6 and dimethylates Arg74 in mouse Smad6 as identified by mass spectrometry.","method":"In vitro methylation assay, mass spectrometry, co-immunoprecipitation, mutagenesis (Smad6-R74A)","journal":"FEBS Letters","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution of methylation, mass-spectrometric identification of modified residue, domain mapping","pmids":["17118358"],"is_preprint":false},{"year":2009,"finding":"Smad6 directly interacts with Tbx6 through its MH2 domain (binding residues 90-180 of Tbx6) and recruits Smurf1 to facilitate ubiquitin-proteasome-dependent degradation of Tbx6, thereby reducing Tbx6-mediated Myf-5 gene activation.","method":"Co-immunoprecipitation, domain mapping, ubiquitination/degradation assays, siRNA knockdown, reporter assays","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — direct binding with domain mapping, functional ubiquitination assay, and gene expression readout","pmids":["19561075"],"is_preprint":false},{"year":2011,"finding":"TGF-β1-induced Smad6 (but not Smad7) recruits Smurf1 and Smurf2 E3 ubiquitin ligases to mediate K48-linked polyubiquitination and proteasomal degradation of the TLR adaptor MyD88, thereby inhibiting MyD88-dependent pro-inflammatory NF-κB signaling.","method":"Co-immunoprecipitation, ubiquitin linkage assays, siRNA knockdown, NF-κB reporter assays, gene expression analysis","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 — mechanistic dissection of K48 ubiquitin linkage, Smad6-specificity vs Smad7, Smurf1/2 dependence by siRNA","pmids":["21897371"],"is_preprint":false},{"year":2011,"finding":"Smad6 promotes neuronal differentiation in the intermediate zone of the chick dorsal spinal cord by inhibiting both BMP signaling and the Wnt/β-catenin pathway; the inhibition of Wnt/β-catenin is independent of BMP inhibition and is mediated through the N-terminal domain and linker region of Smad6, which enhances CtBP interaction with the β-catenin/TCF complex.","method":"In ovo knockdown experiments (chick), reporter assays, co-immunoprecipitation, domain deletion analysis","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 — in vivo knockdown with defined phenotype plus mechanistic dissection by domain mutants and Co-IP","pmids":["21730158"],"is_preprint":false},{"year":2013,"finding":"Smad6 (but not Smad7) negatively regulates the noncanonical TGF-β1-TRAF6-TAK1-p38 MAPK/JNK pathway by recruiting the deubiquitinase A20 to TRAF6, removing K63-linked polyubiquitin chains from TRAF6 and preventing TAK1 activation.","method":"Co-immunoprecipitation, ubiquitin linkage assays, siRNA knockdown in cells and in vivo animal models, MAPK phosphorylation assays","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 — direct A20-Smad6-TRAF6 complex shown, K63 deubiquitination mechanism, validated in vivo","pmids":["24096742"],"is_preprint":false},{"year":2013,"finding":"UBE2O (E2-230K) functions as an E2-E3 hybrid enzyme that monoubiquitinates SMAD6 at lysine 174; monoubiquitinated SMAD6 has impaired binding to the BMP type I receptor, reducing its inhibitory activity toward BMP7 signaling, and this modification promotes BMP7-induced adipogenesis.","method":"Proteomic interaction screen, in vitro ubiquitination assay, mutagenesis (Lys174 and Cys885 of UBE2O), co-immunoprecipitation, BMP signaling reporter assays, adipogenesis assays","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro ubiquitination reconstitution, site-specific mutagenesis, functional consequence on receptor binding and signaling","pmids":["23455153"],"is_preprint":false},{"year":2015,"finding":"Arkadia (an E3 ubiquitin ligase) induces ubiquitylation and proteasome-dependent degradation of Smad6 (in addition to Smad7 and c-Ski/SnoN); wild-type Arkadia but not the catalytically inactive C937A mutant causes Smad6 degradation, thereby enhancing BMP-induced osteoblast differentiation.","method":"Ubiquitylation assay, proteasome inhibitor treatment, Arkadia knockdown/KO MEFs, luciferase reporter assays, mutagenesis","journal":"Journal of Biochemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro ubiquitylation, catalytic mutant control, KO cell validation","pmids":["25762727"],"is_preprint":false},{"year":2018,"finding":"Nuclear Smad6 directly interacts with PIAS3 through its MH2 domain, recruits Smurf1 (via Smad6's MH2 domain and PY motif) to promote PIAS3 ubiquitination and degradation, thereby reducing PIAS3-mediated STAT3 inhibition and enhancing STAT3-driven glioma cell growth.","method":"Co-immunoprecipitation, domain mapping, ubiquitination assays, siRNA knockdown, cell growth and stem-cell initiation assays","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 — direct binding with domain mapping, mechanistic ubiquitination assay, functional tumor cell readout","pmids":["29950561"],"is_preprint":false},{"year":2018,"finding":"PRMT1-induced arginine methylation of Smad6 enables Smad6 to recruit MyD88 and promote its degradation, thereby inhibiting TLR-NF-κB signaling; disruption of Smad6 methylation exacerbates inflammation and bone loss in experimental periodontitis.","method":"Co-immunoprecipitation, in vitro methylation assay, siRNA knockdown, NF-κB reporter assays, in vivo periodontitis model","journal":"Journal of Dental Research","confidence":"High","confidence_rationale":"Tier 2 — methylation-dependent mechanism with in vitro and in vivo validation, functional consequence","pmids":["29420098"],"is_preprint":false},{"year":2021,"finding":"SMAD6 functions downstream of ligand-induced Notch1 signaling and upstream of the vascular protocadherin PCDH12 to transduce endothelial cell flow-mediated responses; loss of SMAD6 in endothelial cells causes defective barrier function, upregulation of proliferation-associated genes, downregulation of junction genes, and impaired flow-mediated alignment.","method":"siRNA knockdown, endothelial cell flow assays, genetic rescue with full-length SMAD6, gene expression analysis, Notch1 pathway manipulation","journal":"Angiogenesis","confidence":"High","confidence_rationale":"Tier 2 — epistasis established by concomitant Notch1/SMAD6 manipulation, PCDH12 placed downstream, specific functional readouts","pmids":["33779885"],"is_preprint":false},{"year":2011,"finding":"Loss of Smad6 in mice leads to skeletal defects including posterior vertebral transformation, bilateral ossification centers, bifid sternebrae, and an expanded hypertrophic zone in growth plates due to increased BMP responsiveness in Smad6-deficient chondrocytes, establishing Smad6 as an essential intracellular limiter of BMP signaling during endochondral bone formation.","method":"Smad6 knockout mouse, histological analysis, BMP responsiveness assays in isolated chondrocytes","journal":"Journal of Bone and Mineral Research","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined skeletal phenotypes and BMP responsiveness assay in isolated cells","pmids":["21681813"],"is_preprint":false},{"year":2011,"finding":"JNK1 activation decreases binding of inhibitory Smad6 to the type I BMP receptor (BMPR-I) and reciprocally increases binding of Smad1 to BMPR-I, thereby increasing cellular responsiveness to BMP-2 and promoting osteoblast differentiation.","method":"JNK gain- and loss-of-function, co-immunoprecipitation of Smad6/Smad1 with BMPR-I, osteoblast differentiation and mineralization assays","journal":"Journal of Bone and Mineral Research","confidence":"Medium","confidence_rationale":"Tier 2 — direct receptor binding assay, functional differentiation readout, single lab","pmids":["21542012"],"is_preprint":false},{"year":2011,"finding":"Runx1 directly regulates Smad6 expression in the aorta-gonad-mesonephros region via a novel upstream enhancer (with Fli1, Gata2, and Scl), establishing a rheostat in which Runx1 drives its own negative control through Smad6-mediated proteasomal targeting of Runx1.","method":"ChIP in AGM region, Runx1 KO embryo analysis, proteasome inhibitor experiments, enhancer reporter assays","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 2 — ChIP in vivo, KO embryo, functional enhancer validation, epistasis established","pmids":["21576367"],"is_preprint":false},{"year":2009,"finding":"Smad6 inhibits the Wnt/β-catenin pathway in hepatic progenitor cells by promoting CtBP interaction with the β-catenin/TCF complex to inhibit β-catenin-mediated transcriptional activation, suppressing HPC proliferation and self-renewal.","method":"Ectopic expression, siRNA knockdown of β-catenin, co-immunoprecipitation, reporter assays, proliferation assays","journal":"Journal of Cellular Physiology","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, mechanistic Co-IP and reporter, but limited orthogonal validation","pmids":["24446200"],"is_preprint":false},{"year":2007,"finding":"BMP-2 activates Smad6 gene transcription via a bone-specific OSE2-a element in the Smad6 promoter through the combined action of Runx2 and BMP-activated Smad1; Smad1 excludes Smurf1 from the OSE2 site, promoting Smad6 transcription, while Smurf1 inhibits it.","method":"Promoter deletion/mutation analysis, luciferase reporter assays, EMSA, ChIP assays","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — direct DNA binding shown by EMSA and ChIP, mutagenesis of OSE2-a site","pmids":["17215250"],"is_preprint":false},{"year":2006,"finding":"Smad6 interacts with Dlx3 (via residues 80-163 of Dlx3 including part of the homeodomain) and Dlx4 homeobox transcription factors in the nucleus of trophoblasts, inhibiting Dlx3 binding to specific target gene promoter sites and repressing Dlx3-dependent transcription.","method":"Co-immunoprecipitation, immunocytochemistry, in vitro protein interaction with deletion mutants, EMSA, luciferase reporter assays, siRNA knockdown","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, domain mapping, functional reporter and siRNA confirmation","pmids":["16687405"],"is_preprint":false},{"year":2016,"finding":"Notch signaling sets endothelial cell BMP responsiveness by regulating SMAD6 expression upstream of BMP target gene transcription; SMAD6 acts as a cell-intrinsic BMP inhibitor downstream of Notch, controlling lateral vessel branching in response to pro-angiogenic BMP2 and BMP6 ligands.","method":"Zebrafish in vivo model, endothelial cell in vitro BMP assays, Notch pathway manipulation, SMAD6 overexpression/knockdown","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 — in vivo and in vitro validation, genetic epistasis (Notch→SMAD6→BMP response), multiple readouts","pmids":["27834400"],"is_preprint":false},{"year":2017,"finding":"AMPK activation upregulates Smad6 and Smurf1 and enhances their interaction, leading to proteasome-dependent degradation of ALK2 (including the FOP-associated ALK2-R206H mutant); knockdown of either Smad6 or Smurf1 prevents metformin-induced ALK2 reduction.","method":"Co-immunoprecipitation, siRNA knockdown of Smad6/Smurf1, proteasome inhibitor assays, AMPK gain/loss-of-function, FOP patient-derived iPS cells","journal":"Biochimica et Biophysica Acta","confidence":"High","confidence_rationale":"Tier 2 — mechanistic Co-IP, siRNA epistasis, proteasome inhibitor validation, patient-derived cells","pmids":["28847510"],"is_preprint":false},{"year":2018,"finding":"SMAD6 loss in murine development causes vessel hemorrhage associated with increased VE-cadherin endocytosis, disrupted endothelial adherens junctions, increased vessel branching and sprouting in postnatal retinal vessels, placing SMAD6 as essential for vascular junction stabilization.","method":"Conditional/global SMAD6 KO mice, retinal vessel imaging, endothelial cell junction analysis, VE-cadherin endocytosis assay, siRNA knockdown in vitro","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 — KO mouse with specific vascular phenotype, mechanistic in vitro follow-up on junctions","pmids":["30098998"],"is_preprint":false},{"year":2001,"finding":"Smad6 and Smad7 inhibit BMP2-induced neurite outgrowth in PC12 cells by interacting physically with TAK1-binding protein (TAB1), a molecule required for TAK1 activation, thereby blocking the TAK1-p38 kinase pathway.","method":"Co-immunoprecipitation of Smad6/7 with TAB1, kinase-negative TAK1 expression, neurite outgrowth assay, p38 phosphorylation assay","journal":"Genes to Cells","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding to TAB1 shown by Co-IP, functional kinase-dead rescue, single lab","pmids":["11737269"],"is_preprint":false}],"current_model":"SMAD6 is an inhibitory SMAD that negatively regulates BMP/TGF-β superfamily signaling through multiple mechanisms: (1) it binds stably to BMP type I receptors (preferentially ALK-3/6) to block receptor-regulated SMAD phosphorylation; (2) it acts as a Smad4 decoy by competing with Smad4 for binding to phosphorylated Smad1, forming an inactive Smad1-Smad6 complex; (3) in the nucleus it recruits corepressors CtBP and HDAC3 to repress BMP target gene transcription and acts as a corepressor with Hox transcription factors; (4) it blocks non-canonical signaling by binding TAK1 or recruiting the deubiquitinase A20 to TRAF6 to remove K63-linked polyubiquitin; (5) it scaffolds Smurf1/Smurf2 E3 ligases to mediate degradation of substrates including Runx2, Tbx6, PIAS3, and MyD88; (6) it is itself post-translationally regulated by UBE2O-mediated monoubiquitination at Lys174 (reducing receptor binding), PRMT1-mediated arginine methylation at Arg74, PrKX-mediated serine phosphorylation, and Arkadia-mediated ubiquitylation/degradation; and (7) its expression is transcriptionally induced by BMP-activated Smad1/5-Smad4 complexes binding a GC-rich element in its promoter, establishing a negative feedback loop essential for cardiovascular, skeletal, and hematopoietic development."},"narrative":{"teleology":[{"year":1997,"claim":"Identification of SMAD6 as an inhibitory SMAD that stably associates with TGF-β/BMP type I receptors and blocks R-SMAD phosphorylation established the existence of intracellular antagonists within the SMAD signaling cascade.","evidence":"Co-immunoprecipitation and phosphorylation assays in transfected mammalian cells","pmids":["9335505"],"confidence":"High","gaps":["Receptor subtype specificity not yet defined","Nuclear versus cytoplasmic site of action unclear","Post-translational regulation of SMAD6 unknown"]},{"year":1998,"claim":"Demonstration that SMAD6 acts as a SMAD4 decoy — competing with SMAD4 for binding to phosphorylated SMAD1 to form an inactive complex — revealed a second inhibitory mechanism independent of receptor blockade and explained SMAD6's preference for BMP over TGF-β signaling.","evidence":"Co-immunoprecipitation in mammalian cells and functional assays in Xenopus embryos","pmids":["9436979"],"confidence":"High","gaps":["Whether SMAD6 employs both mechanisms simultaneously in physiological contexts not resolved","Structural basis of SMAD1-SMAD6 versus SMAD1-SMAD4 competition unknown"]},{"year":2000,"claim":"Four simultaneous discoveries in 2000 defined the physiological importance and mechanistic breadth of SMAD6: knockout mice revealed essential cardiovascular roles; SMAD6 was shown to block non-canonical BMP-TAK1-p38 signaling by binding TAK1; nuclear corepressor function was established through interaction with Hoxc-8; and BMP-responsive promoter elements were identified, closing the negative feedback loop.","evidence":"Smad6 KO mice with cardiac valve/outflow tract defects; Co-IP of SMAD6-TAK1 with kinase-dead rescue; yeast two-hybrid and EMSA for SMAD6-Hoxc-8 DNA binding; promoter deletion and EMSA for SMAD1/5-SMAD4 binding to GCCGnCGC element","pmids":["10655064","10748100","10722652","10692396"],"confidence":"High","gaps":["TAK1 binding mechanism and whether it involves TAB1 or is direct not fully resolved","Relative contribution of receptor-level versus nuclear inhibition in vivo unclear","Feedback loop dynamics not quantified"]},{"year":2003,"claim":"Identification of CtBP as a SMAD6-recruited corepressor via a PLDLS motif in the linker region established the molecular basis of SMAD6's transcriptional repressor activity at BMP target genes such as Id1.","evidence":"Co-IP and mutagenesis of PLDLS motif with BMP-responsive reporter assays","pmids":["14645520"],"confidence":"High","gaps":["Genome-wide targets of SMAD6-CtBP repression not defined","Whether CtBP and HDAC3 corepressor activities are independent or cooperative unclear"]},{"year":2005,"claim":"Discovery that SMAD6 scaffolds the Smurf1 E3 ligase to Runx2 for ubiquitin-proteasomal degradation, and independently recruits HDAC3 to suppress glucocorticoid receptor transcription, revealed SMAD6 as a versatile adaptor for both protein degradation and chromatin modification beyond canonical SMAD pathways.","evidence":"Reciprocal Co-IP of SMAD6-Runx2-Smurf1 with proteasome inhibitor controls; Co-IP of SMAD6-GR-HDAC3 with chromatin acetylation assays and in vivo adenoviral delivery","pmids":["16299379","16249187"],"confidence":"High","gaps":["Full repertoire of SMAD6-Smurf substrates not catalogued","Whether SMAD6-HDAC3 interaction is direct or bridged unknown"]},{"year":2006,"claim":"Multiple 2006 studies expanded SMAD6's regulatory network: post-translational modifications by PrKX (serine phosphorylation) and PRMT1 (Arg74 methylation) were mapped; anti-inflammatory function through disruption of the IRAK1-Pellino-1-TRAF6 complex was demonstrated; Notch-driven SMAD6 expression was shown to set BMP responsiveness; and nuclear interactions with Dlx3/4 homeodomain factors in trophoblasts were established.","evidence":"In vitro kinase and methylation assays with mass spectrometry and mutagenesis; Co-IP of SMAD6-Pellino-1 with NF-κB reporter and siRNA; SMAD6 interaction with Dlx3 by Co-IP, EMSA, and siRNA","pmids":["16491121","17118358","16951688","16687405"],"confidence":"High","gaps":["Functional consequence of Arg74 methylation on SMAD6 activity not fully characterized in this year","Cross-talk between phosphorylation and methylation modifications unknown","Whether Pellino-1 binding and Smurf scaffolding are mutually exclusive unclear"]},{"year":2007,"claim":"Receptor subtype specificity of SMAD6 was resolved: SMAD6 preferentially inhibits ALK-3/6 over ALK-1/2, with specific kinase domain residues (Arg-238, Phe-264, Thr-265, Ala-269) determining sensitivity; additionally, Runx2-dependent bone-specific Smad6 transcription through an OSE2-a promoter element was identified.","evidence":"Mutagenesis of ALK-3 kinase domain residues with Co-IP and reporter assays; promoter deletion, EMSA, and ChIP for OSE2-a element","pmids":["17493940","17215250"],"confidence":"High","gaps":["Structural basis of SMAD6-ALK3 kinase domain interaction not determined","Whether ALK-1/2 escape from SMAD6 inhibition is physiologically important in specific tissues unknown"]},{"year":2009,"claim":"Extension of the SMAD6-Smurf scaffolding paradigm to Tbx6 degradation showed SMAD6's MH2 domain bridges Smurf1 to diverse transcription factor substrates, establishing a generalizable adaptor mechanism.","evidence":"Co-IP with domain mapping, ubiquitination and degradation assays, siRNA knockdown, and Myf-5 reporter readout","pmids":["19561075"],"confidence":"High","gaps":["Whether SMAD6-Smurf targets other T-box family members not tested","In vivo significance for somitogenesis not demonstrated"]},{"year":2011,"claim":"A cluster of 2011 studies defined SMAD6's roles in innate immunity, Wnt inhibition, skeletal development, and hematopoietic feedback: SMAD6 recruits Smurf1/2 for K48-linked ubiquitination and degradation of MyD88; SMAD6 inhibits Wnt/β-catenin signaling by enhancing CtBP-β-catenin/TCF interaction during neural differentiation; Smad6 KO mice exhibit vertebral and growth plate defects from excess BMP signaling; JNK1 reduces SMAD6-receptor binding to enhance BMP responsiveness; and Runx1 drives Smad6 expression to create a self-limiting hematopoietic feedback loop.","evidence":"Co-IP with ubiquitin linkage assays and NF-κB reporters; in ovo knockdown in chick with domain deletion analysis; Smad6 KO mouse skeletal phenotyping with chondrocyte BMP assays; JNK gain/loss-of-function with receptor Co-IP; ChIP in AGM region with Runx1 KO embryos","pmids":["21897371","21730158","21681813","21542012","21576367"],"confidence":"High","gaps":["Whether SMAD6-mediated Wnt inhibition operates beyond neural and hepatic contexts not established","Mechanism by which JNK1 displaces SMAD6 from receptors not molecularly defined","Relative contributions of Smurf1 versus Smurf2 to MyD88 degradation not resolved"]},{"year":2013,"claim":"Two key regulatory mechanisms were uncovered: SMAD6 recruits deubiquitinase A20 to remove K63-polyubiquitin from TRAF6, blocking non-canonical TGF-β1-TAK1 signaling; and UBE2O monoubiquitinates SMAD6 at Lys174, impairing receptor binding and thereby relieving SMAD6's inhibition of BMP7 signaling to promote adipogenesis.","evidence":"Co-IP of A20-SMAD6-TRAF6 with K63 deubiquitination assays and in vivo validation; in vitro ubiquitination reconstitution with Lys174 mutagenesis, receptor binding assays, and adipogenesis readout","pmids":["24096742","23455153"],"confidence":"High","gaps":["Whether A20 recruitment and Smurf scaffolding occur on the same or different SMAD6 pools unknown","Other monoubiquitination sites on SMAD6 not surveyed","Tissue-specific regulation of UBE2O-SMAD6 axis not explored"]},{"year":2015,"claim":"Arkadia (RNF111) was identified as an E3 ligase that ubiquitinates and degrades SMAD6 via the proteasome, providing a mechanism for relieving SMAD6-imposed BMP inhibition during osteoblast differentiation.","evidence":"Ubiquitylation assay with catalytic mutant C937A, proteasome inhibitor treatment, Arkadia KO MEFs, BMP reporter assays","pmids":["25762727"],"confidence":"High","gaps":["Whether Arkadia targets SMAD6 in non-bone contexts unknown","Lysine residues on SMAD6 targeted by Arkadia not mapped"]},{"year":2017,"claim":"AMPK activation was shown to upregulate both SMAD6 and Smurf1 and enhance their interaction, leading to degradation of the BMP type I receptor ALK2, including the disease-associated ALK2-R206H FOP mutant — revealing a pharmacologically targetable SMAD6-dependent receptor turnover pathway.","evidence":"Co-IP and siRNA epistasis for SMAD6-Smurf1-ALK2, proteasome inhibitor validation, FOP patient-derived iPSCs","pmids":["28847510"],"confidence":"High","gaps":["Whether SMAD6-Smurf1 targets other type I receptors beyond ALK2 via AMPK not tested","In vivo therapeutic efficacy not demonstrated"]},{"year":2018,"claim":"Three 2018 studies revealed new dimensions of SMAD6 function: PRMT1-mediated methylation enables SMAD6 to recruit and degrade MyD88, limiting inflammation and bone loss; nuclear SMAD6 scaffolds Smurf1 to degrade the STAT3 inhibitor PIAS3, promoting glioma growth; and SMAD6 loss causes vascular hemorrhage through increased VE-cadherin endocytosis and disrupted adherens junctions.","evidence":"In vitro methylation with in vivo periodontitis model; Co-IP and domain mapping of SMAD6-PIAS3-Smurf1 with glioma cell growth assays; conditional/global SMAD6 KO mice with retinal vessel imaging and VE-cadherin endocytosis assay","pmids":["29420098","29950561","30098998"],"confidence":"High","gaps":["Whether SMAD6-PIAS3 axis operates in tumors beyond glioma not tested","Direct mechanism linking SMAD6 loss to VE-cadherin endocytosis not molecularly defined","Methylation-dependent substrate selection by SMAD6 not systematically addressed"]},{"year":2021,"claim":"SMAD6 was placed in a Notch1→SMAD6→PCDH12 signaling axis in endothelial cells that controls flow-mediated responses, barrier function, and junctional gene expression, extending SMAD6's vascular roles beyond BMP inhibition.","evidence":"siRNA knockdown and genetic rescue in endothelial cells under flow, epistasis with Notch1 pathway manipulation, gene expression profiling","pmids":["33779885"],"confidence":"High","gaps":["Whether SMAD6's role in flow sensing requires its BMP-inhibitory or scaffolding activities unknown","Mechanism by which SMAD6 regulates PCDH12 expression not resolved"]},{"year":null,"claim":"Major unresolved questions include the structural basis of SMAD6's selective interaction with ALK-3/6, how multiple post-translational modifications (ubiquitination, methylation, phosphorylation) are integrated to regulate SMAD6 activity in specific cellular contexts, and whether SMAD6's diverse scaffolding, corepressor, and decoy functions are partitioned by subcellular localization or by distinct SMAD6 pools.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal structure of SMAD6 in complex with any receptor or partner","Systematic identification of all SMAD6-Smurf substrates lacking","Integration of multiple PTMs on a single SMAD6 molecule not studied"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[8,13,14,19,29]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,2,5,16]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[3,7,9,27]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3,7,9,11,19,27]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,1,2,5,10,16]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,2,5,6,15,16,28]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4,22,30]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10,14,20]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[8,13,14,17,18,19]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[3,7,9,27]}],"complexes":[],"partners":["SMURF1","SMURF2","SMAD1","MAP3K7","TNFAIP3","TRAF6","CTBP1","UBE2O"],"other_free_text":[]},"mechanistic_narrative":"SMAD6 is an inhibitory SMAD that serves as a central negative regulator of BMP/TGF-β superfamily signaling and inflammatory pathways through multiple cytoplasmic and nuclear mechanisms. In the cytoplasm, SMAD6 binds preferentially to BMP type I receptors ALK-3/6 to block R-SMAD phosphorylation, acts as a SMAD4 decoy by forming inactive complexes with phosphorylated SMAD1, inhibits non-canonical TAK1-p38 signaling by binding TAK1 and recruiting deubiquitinase A20 to TRAF6, and scaffolds Smurf1/Smurf2 E3 ligases to target substrates including Runx2, Tbx6, MyD88, PIAS3, and ALK2 for proteasomal degradation [PMID:9335505, PMID:9436979, PMID:10748100, PMID:24096742, PMID:16299379, PMID:21897371, PMID:29950561]. In the nucleus, SMAD6 recruits corepressors CtBP and HDAC3 to repress BMP target genes and glucocorticoid receptor targets, acts as a corepressor with Hox and Dlx transcription factors, and inhibits Wnt/β-catenin signaling by promoting CtBP interaction with the β-catenin/TCF complex [PMID:14645520, PMID:16249187, PMID:10722652, PMID:21730158]. SMAD6 itself is regulated post-translationally by UBE2O-mediated monoubiquitination at Lys174, PRMT1 methylation at Arg74, PrKX phosphorylation, Arkadia-mediated degradation, and JNK1-dependent modulation of receptor binding, while its transcription is driven by BMP-activated SMAD1/5-SMAD4 through a GC-rich promoter element and by Runx2 through a bone-specific OSE2-a element, establishing tissue-specific negative feedback loops essential for cardiovascular, skeletal, vascular, and hematopoietic development [PMID:23455153, PMID:17118358, PMID:16491121, PMID:25762727, PMID:10692396, PMID:17215250, PMID:10655064, PMID:21681813, PMID:30098998]."},"prefetch_data":{"uniprot":{"accession":"O43541","full_name":"SMAD family member 6","aliases":["Mothers against decapentaplegic homolog 6","MAD homolog 6","Mothers against DPP homolog 6"],"length_aa":496,"mass_kda":53.5,"function":"Transforming growth factor-beta superfamily receptors signaling occurs through the Smad family of intracellular mediators. SMAD6 is an inhibitory Smad (i-Smad) that negatively regulates signaling downstream of type I transforming growth factor-beta (PubMed:10647776, PubMed:10708948, PubMed:10708949, PubMed:16951688, PubMed:22275001, PubMed:30848080, PubMed:9436979, PubMed:9759503). Acts as a mediator of TGF-beta and BMP anti-inflammatory activities. Suppresses IL1R-TLR signaling through its direct interaction with PEL1, preventing NF-kappa-B activation, nuclear transport and NF-kappa-B-mediated expression of pro-inflammatory genes (PubMed:16951688). Blocks the BMP-SMAD1 signaling pathway by competing with SMAD4 for receptor-activated SMAD1-binding (PubMed:30848080, PubMed:9436979). Binds to regulatory elements in target promoter regions (PubMed:16491121)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/O43541/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SMAD6","classification":"Not Classified","n_dependent_lines":28,"n_total_lines":1208,"dependency_fraction":0.023178807947019868},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SMAD6","total_profiled":1310},"omim":[{"mim_id":"617439","title":"CRANIOSYNOSTOSIS 7; CRS7","url":"https://www.omim.org/entry/617439"},{"mim_id":"614823","title":"AORTIC VALVE DISEASE 2; AOVD2","url":"https://www.omim.org/entry/614823"},{"mim_id":"614797","title":"PELLINO E3 UBIQUITIN PROTEIN LIGASE 1; PELI1","url":"https://www.omim.org/entry/614797"},{"mim_id":"611274","title":"GLAUCOMA 1, OPEN ANGLE, N; GLC1N","url":"https://www.omim.org/entry/611274"},{"mim_id":"605600","title":"IMPORTIN 8; IPO8","url":"https://www.omim.org/entry/605600"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear bodies","reliability":"Supported"},{"location":"Golgi apparatus","reliability":"Additional"},{"location":"Primary cilium","reliability":"Additional"},{"location":"Basal body","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"heart muscle","ntpm":28.9},{"tissue":"lung","ntpm":26.3}],"url":"https://www.proteinatlas.org/search/SMAD6"},"hgnc":{"alias_symbol":["HsT17432"],"prev_symbol":["MADH7","MADH6"]},"alphafold":{"accession":"O43541","domains":[{"cath_id":"3.90.520.10","chopping":"164-270","consensus_level":"high","plddt":92.4305,"start":164,"end":270},{"cath_id":"2.60.200.10","chopping":"333-450_459-493","consensus_level":"high","plddt":91.6427,"start":333,"end":493}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O43541","model_url":"https://alphafold.ebi.ac.uk/files/AF-O43541-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O43541-F1-predicted_aligned_error_v6.png","plddt_mean":70.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SMAD6","jax_strain_url":"https://www.jax.org/strain/search?query=SMAD6"},"sequence":{"accession":"O43541","fasta_url":"https://rest.uniprot.org/uniprotkb/O43541.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O43541/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O43541"}},"corpus_meta":[{"pmid":"9335505","id":"PMC_9335505","title":"Smad6 inhibits signalling by the TGF-beta superfamily.","date":"1997","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9335505","citation_count":874,"is_preprint":false},{"pmid":"9436979","id":"PMC_9436979","title":"Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor.","date":"1998","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9436979","citation_count":579,"is_preprint":false},{"pmid":"10655064","id":"PMC_10655064","title":"A role for smad6 in development and homeostasis of the cardiovascular system.","date":"2000","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10655064","citation_count":388,"is_preprint":false},{"pmid":"9712726","id":"PMC_9712726","title":"Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9712726","citation_count":300,"is_preprint":false},{"pmid":"10692396","id":"PMC_10692396","title":"Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10692396","citation_count":230,"is_preprint":false},{"pmid":"10748100","id":"PMC_10748100","title":"BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10748100","citation_count":202,"is_preprint":false},{"pmid":"10224135","id":"PMC_10224135","title":"Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10224135","citation_count":191,"is_preprint":false},{"pmid":"27606499","id":"PMC_27606499","title":"Two locus inheritance of non-syndromic midline craniosynostosis via rare SMAD6 and common BMP2 alleles.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/27606499","citation_count":162,"is_preprint":false},{"pmid":"11376113","id":"PMC_11376113","title":"Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.","date":"2001","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/11376113","citation_count":144,"is_preprint":false},{"pmid":"9514869","id":"PMC_9514869","title":"Induction of Smad6 mRNA by bone morphogenetic proteins.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9514869","citation_count":138,"is_preprint":false},{"pmid":"17493940","id":"PMC_17493940","title":"Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17493940","citation_count":130,"is_preprint":false},{"pmid":"16299379","id":"PMC_16299379","title":"Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16299379","citation_count":127,"is_preprint":false},{"pmid":"10722652","id":"PMC_10722652","title":"Smad6 as a transcriptional corepressor.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10722652","citation_count":119,"is_preprint":false},{"pmid":"21897371","id":"PMC_21897371","title":"Smad6-specific recruitment of Smurf E3 ligases mediates TGF-β1-induced degradation of MyD88 in TLR4 signalling.","date":"2011","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/21897371","citation_count":119,"is_preprint":false},{"pmid":"16951688","id":"PMC_16951688","title":"Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1.","date":"2006","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16951688","citation_count":113,"is_preprint":false},{"pmid":"22275001","id":"PMC_22275001","title":"Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation.","date":"2012","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/22275001","citation_count":97,"is_preprint":false},{"pmid":"10049697","id":"PMC_10049697","title":"Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10049697","citation_count":91,"is_preprint":false},{"pmid":"24096742","id":"PMC_24096742","title":"Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6.","date":"2013","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24096742","citation_count":90,"is_preprint":false},{"pmid":"27834400","id":"PMC_27834400","title":"Notch regulates BMP responsiveness and lateral branching in vessel networks via SMAD6.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27834400","citation_count":85,"is_preprint":false},{"pmid":"28659821","id":"PMC_28659821","title":"Candidate Gene Resequencing in a Large Bicuspid Aortic Valve-Associated Thoracic Aortic Aneurysm Cohort: SMAD6 as an Important Contributor.","date":"2017","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28659821","citation_count":84,"is_preprint":false},{"pmid":"23455153","id":"PMC_23455153","title":"Fine-tuning BMP7 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6.","date":"2013","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/23455153","citation_count":80,"is_preprint":false},{"pmid":"14645520","id":"PMC_14645520","title":"Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14645520","citation_count":79,"is_preprint":false},{"pmid":"10525349","id":"PMC_10525349","title":"Evidence for a role of Smad6 in chick cardiac development.","date":"1999","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10525349","citation_count":72,"is_preprint":false},{"pmid":"32375794","id":"PMC_32375794","title":"Saliva exosomes-derived UBE2O mRNA promotes angiogenesis in cutaneous wounds by targeting SMAD6.","date":"2020","source":"Journal of nanobiotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/32375794","citation_count":71,"is_preprint":false},{"pmid":"10801843","id":"PMC_10801843","title":"Smad7 and Smad6 differentially modulate transforming growth factor beta -induced inhibition of embryonic lung morphogenesis.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10801843","citation_count":68,"is_preprint":false},{"pmid":"15766759","id":"PMC_15766759","title":"Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation.","date":"2005","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15766759","citation_count":67,"is_preprint":false},{"pmid":"9734784","id":"PMC_9734784","title":"Smad6 functions as an intracellular antagonist of some TGF-beta family members during Xenopus embryogenesis.","date":"1998","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/9734784","citation_count":65,"is_preprint":false},{"pmid":"22283839","id":"PMC_22283839","title":"Up-regulation of BMP-2 antagonizes TGF-β1/ROCK-enhanced cardiac fibrotic signalling through activation of Smurf1/Smad6 complex.","date":"2012","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22283839","citation_count":61,"is_preprint":false},{"pmid":"21681813","id":"PMC_21681813","title":"Smad6 is essential to limit BMP signaling during cartilage development.","date":"2011","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/21681813","citation_count":58,"is_preprint":false},{"pmid":"21698246","id":"PMC_21698246","title":"Preferential activation of SMAD1/5/8 on the fibrosa endothelium in calcified human aortic valves--association with low BMP antagonists and SMAD6.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21698246","citation_count":55,"is_preprint":false},{"pmid":"17215250","id":"PMC_17215250","title":"Bone morphogenetic protein 2 activates Smad6 gene transcription through bone-specific transcription factor Runx2.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17215250","citation_count":54,"is_preprint":false},{"pmid":"19047146","id":"PMC_19047146","title":"SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19047146","citation_count":54,"is_preprint":false},{"pmid":"29950561","id":"PMC_29950561","title":"Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29950561","citation_count":54,"is_preprint":false},{"pmid":"16676428","id":"PMC_16676428","title":"Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring.","date":"2006","source":"Journal of plastic, reconstructive & aesthetic surgery : JPRAS","url":"https://pubmed.ncbi.nlm.nih.gov/16676428","citation_count":53,"is_preprint":false},{"pmid":"14633701","id":"PMC_14633701","title":"Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.","date":"2003","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/14633701","citation_count":53,"is_preprint":false},{"pmid":"9205116","id":"PMC_9205116","title":"Cloning and characterization of a novel member of the human Mad gene family (MADH6).","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9205116","citation_count":46,"is_preprint":false},{"pmid":"20881435","id":"PMC_20881435","title":"Breast milk-transforming growth factor-β₂ specifically attenuates IL-1β-induced inflammatory responses in the immature human intestine via an SMAD6- and ERK-dependent mechanism.","date":"2010","source":"Neonatology","url":"https://pubmed.ncbi.nlm.nih.gov/20881435","citation_count":46,"is_preprint":false},{"pmid":"25864564","id":"PMC_25864564","title":"Protective Role of Smad6 in Inflammation-Induced Valvular Cell Calcification.","date":"2015","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25864564","citation_count":44,"is_preprint":false},{"pmid":"11231077","id":"PMC_11231077","title":"Developmentally regulated expression of Smad3, Smad4, Smad6, and Smad7 involved in TGF-beta signaling.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11231077","citation_count":44,"is_preprint":false},{"pmid":"16249187","id":"PMC_16249187","title":"The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16249187","citation_count":44,"is_preprint":false},{"pmid":"11737269","id":"PMC_11737269","title":"Inhibition of BMP2-induced, TAK1 kinase-mediated neurite outgrowth by Smad6 and Smad7.","date":"2001","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/11737269","citation_count":42,"is_preprint":false},{"pmid":"32304765","id":"PMC_32304765","title":"MicroRNA-374a-5p inhibits neuroinflammation in neonatal hypoxic-ischemic encephalopathy via regulating NLRP3 inflammasome targeted Smad6.","date":"2020","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32304765","citation_count":42,"is_preprint":false},{"pmid":"20171181","id":"PMC_20171181","title":"Smad7 and Smad6 bind to discrete regions of Pellino-1 via their MH2 domains to mediate TGF-beta1-induced negative regulation of IL-1R/TLR signaling.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20171181","citation_count":41,"is_preprint":false},{"pmid":"14755548","id":"PMC_14755548","title":"CREB Cooperates with BMP-stimulated Smad signaling to enhance transcription of the Smad6 promoter.","date":"2004","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14755548","citation_count":41,"is_preprint":false},{"pmid":"27693511","id":"PMC_27693511","title":"Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.","date":"2016","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/27693511","citation_count":41,"is_preprint":false},{"pmid":"16373339","id":"PMC_16373339","title":"OAZ regulates bone morphogenetic protein signaling through Smad6 activation.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16373339","citation_count":39,"is_preprint":false},{"pmid":"27113436","id":"PMC_27113436","title":"Smad6 determines BMP-regulated invasive behaviour of breast cancer cells in a zebrafish xenograft model.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27113436","citation_count":39,"is_preprint":false},{"pmid":"32499606","id":"PMC_32499606","title":"SMAD6 variants in craniosynostosis: genotype and phenotype evaluation.","date":"2020","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32499606","citation_count":37,"is_preprint":false},{"pmid":"29420098","id":"PMC_29420098","title":"Smad6 Methylation Represses NFκB Activation and Periodontal Inflammation.","date":"2018","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/29420098","citation_count":37,"is_preprint":false},{"pmid":"12919880","id":"PMC_12919880","title":"Smad6 is induced by BMP-2 and modulates chondrocyte differentiation.","date":"2003","source":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/12919880","citation_count":37,"is_preprint":false},{"pmid":"22896629","id":"PMC_22896629","title":"Semaphorin 7A contributes to West Nile virus pathogenesis through TGF-β1/Smad6 signaling.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/22896629","citation_count":37,"is_preprint":false},{"pmid":"29344637","id":"PMC_29344637","title":"miR‑186, a serum microRNA, induces endothelial cell apoptosis by targeting SMAD6 in Kawasaki disease.","date":"2018","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29344637","citation_count":34,"is_preprint":false},{"pmid":"22960056","id":"PMC_22960056","title":"Smad6 and Smad7 are co-regulated with hepcidin in mouse models of iron overload.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22960056","citation_count":34,"is_preprint":false},{"pmid":"21542012","id":"PMC_21542012","title":"Activation of c-Jun NH(2)-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor.","date":"2011","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/21542012","citation_count":33,"is_preprint":false},{"pmid":"25766838","id":"PMC_25766838","title":"Inhibition of lethal inflammatory responses through the targeting of membrane-associated Toll-like receptor 4 signaling complexes with a Smad6-derived peptide.","date":"2015","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25766838","citation_count":32,"is_preprint":false},{"pmid":"14609530","id":"PMC_14609530","title":"Adenoviral overexpression of Smad-7 and Smad-6 differentially regulates TGF-beta-mediated chondrocyte proliferation and proteoglycan synthesis.","date":"2003","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/14609530","citation_count":32,"is_preprint":false},{"pmid":"33779885","id":"PMC_33779885","title":"SMAD6 transduces endothelial cell flow responses required for blood vessel homeostasis.","date":"2021","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/33779885","citation_count":31,"is_preprint":false},{"pmid":"31592950","id":"PMC_31592950","title":"SMAD6 Genotype Predicts Neurodevelopment in Nonsyndromic Craniosynostosis.","date":"2020","source":"Plastic and reconstructive surgery","url":"https://pubmed.ncbi.nlm.nih.gov/31592950","citation_count":31,"is_preprint":false},{"pmid":"28847510","id":"PMC_28847510","title":"AMPK downregulates ALK2 via increasing the interaction between Smurf1 and Smad6, leading to inhibition of osteogenic differentiation.","date":"2017","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28847510","citation_count":30,"is_preprint":false},{"pmid":"29352111","id":"PMC_29352111","title":"Hepatic SMARCA4 predicts HCC recurrence and promotes tumour cell proliferation by regulating SMAD6 expression.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29352111","citation_count":29,"is_preprint":false},{"pmid":"22450860","id":"PMC_22450860","title":"The CREB-Smad6-Runx2 axis contributes to the impaired osteogenesis potential of bone marrow stromal cells in fibrous dysplasia of bone.","date":"2012","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22450860","citation_count":28,"is_preprint":false},{"pmid":"21730158","id":"PMC_21730158","title":"Smad6 promotes neuronal differentiation in the intermediate zone of the dorsal neural tube by inhibition of the Wnt/beta-catenin pathway.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21730158","citation_count":28,"is_preprint":false},{"pmid":"32022446","id":"PMC_32022446","title":"Foxf2 and Smad6 co-regulation of collagen 5A2 transcription is involved in the pathogenesis of intrauterine adhesion.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32022446","citation_count":27,"is_preprint":false},{"pmid":"12866583","id":"PMC_12866583","title":"Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.","date":"2003","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/12866583","citation_count":27,"is_preprint":false},{"pmid":"31138930","id":"PMC_31138930","title":"SMAD6 is frequently mutated in nonsyndromic radioulnar synostosis.","date":"2019","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31138930","citation_count":27,"is_preprint":false},{"pmid":"32774154","id":"PMC_32774154","title":"Circular RNA hsa_circ_0000517 modulates hepatocellular carcinoma advancement via the miR-326/SMAD6 axis.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/32774154","citation_count":26,"is_preprint":false},{"pmid":"32486965","id":"PMC_32486965","title":"Mesenchymal Behavior of the Endothelium Promoted by SMAD6 Downregulation Is Associated With Brain Arteriovenous Malformation Microhemorrhage.","date":"2020","source":"Stroke","url":"https://pubmed.ncbi.nlm.nih.gov/32486965","citation_count":26,"is_preprint":false},{"pmid":"17118358","id":"PMC_17118358","title":"Methylation of Smad6 by protein arginine N-methyltransferase 1.","date":"2006","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17118358","citation_count":26,"is_preprint":false},{"pmid":"19561075","id":"PMC_19561075","title":"Smad6 inhibits the transcriptional activity of Tbx6 by mediating its degradation.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19561075","citation_count":26,"is_preprint":false},{"pmid":"33938174","id":"PMC_33938174","title":"Hsa-miR-186-5p regulates TGFβ signaling pathway through expression suppression of SMAD6 and SMAD7 genes in colorectal cancer.","date":"2021","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33938174","citation_count":25,"is_preprint":false},{"pmid":"30098998","id":"PMC_30098998","title":"Developmental SMAD6 loss leads to blood vessel hemorrhage and disrupted endothelial cell junctions.","date":"2018","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/30098998","citation_count":24,"is_preprint":false},{"pmid":"21295571","id":"PMC_21295571","title":"Lipopolysaccharide inhibits transforming growth factor-beta1-stimulated Smad6 expression by inducing phosphorylation of the linker region of Smad3 through a TLR4-IRAK1-ERK1/2 pathway.","date":"2011","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/21295571","citation_count":24,"is_preprint":false},{"pmid":"36414630","id":"PMC_36414630","title":"SMAD6-deficiency in human genetic disorders.","date":"2022","source":"NPJ genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36414630","citation_count":22,"is_preprint":false},{"pmid":"33245975","id":"PMC_33245975","title":"Investigation of Genetic Polymorphisms in BMP2, BMP4, SMAD6, and RUNX2 and Persistent Apical Periodontitis.","date":"2020","source":"Journal of endodontics","url":"https://pubmed.ncbi.nlm.nih.gov/33245975","citation_count":21,"is_preprint":false},{"pmid":"16203197","id":"PMC_16203197","title":"Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.","date":"2005","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/16203197","citation_count":21,"is_preprint":false},{"pmid":"16909115","id":"PMC_16909115","title":"Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16909115","citation_count":21,"is_preprint":false},{"pmid":"22670624","id":"PMC_22670624","title":"Molecular Interaction Between Smurfl WW2 Domain and PPXY Motifs of Smadl, Smad5, and Smad6-Modeling and Analysis.","date":"2007","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/22670624","citation_count":21,"is_preprint":false},{"pmid":"16491121","id":"PMC_16491121","title":"Smad6 is a protein kinase X phosphorylation substrate and is required for HL-60 cell differentiation.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16491121","citation_count":21,"is_preprint":false},{"pmid":"11170839","id":"PMC_11170839","title":"Localization of Smad6 and Smad7 in the rat kidney and their regulated expression in the anti-Thy-1 nephritis.","date":"2000","source":"Molecular cell biology research communications : MCBRC","url":"https://pubmed.ncbi.nlm.nih.gov/11170839","citation_count":21,"is_preprint":false},{"pmid":"22705548","id":"PMC_22705548","title":"Inhibition of erythropoiesis by Smad6 in human cord blood hematopoietic stem cells.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22705548","citation_count":20,"is_preprint":false},{"pmid":"33174391","id":"PMC_33174391","title":"HNF1B inhibits cell proliferation via repression of SMAD6 expression in prostate cancer.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33174391","citation_count":18,"is_preprint":false},{"pmid":"21576367","id":"PMC_21576367","title":"A Runx1-Smad6 rheostat controls Runx1 activity during embryonic hematopoiesis.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21576367","citation_count":18,"is_preprint":false},{"pmid":"35845505","id":"PMC_35845505","title":"MiR-20a: a mechanosensitive microRNA that regulates fluid shear stress-mediated osteogenic differentiation via the BMP2 signaling pathway by targeting BAMBI and SMAD6.","date":"2022","source":"Annals of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35845505","citation_count":18,"is_preprint":false},{"pmid":"30135141","id":"PMC_30135141","title":"miR-134 inhibits chondrogenic differentiation of bone marrow mesenchymal stem cells by targetting SMAD6.","date":"2019","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/30135141","citation_count":18,"is_preprint":false},{"pmid":"17676934","id":"PMC_17676934","title":"Molecular interaction between Smurf1 WW2 domain and PPXY motifs of Smad1, Smad5, and Smad6--modeling and analysis.","date":"2007","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/17676934","citation_count":18,"is_preprint":false},{"pmid":"30038786","id":"PMC_30038786","title":"Co-occurrence of frameshift mutations in SMAD6 and TCF12 in a child with complex craniosynostosis.","date":"2018","source":"Human genome variation","url":"https://pubmed.ncbi.nlm.nih.gov/30038786","citation_count":17,"is_preprint":false},{"pmid":"15033458","id":"PMC_15033458","title":"Expressions of inhibitory Smads, Smad6 and Smad7, are differentially regulated by TPA in human lung fibroblast cells.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15033458","citation_count":17,"is_preprint":false},{"pmid":"31832175","id":"PMC_31832175","title":"MicroRNA-186 improves fracture healing through activating the bone morphogenetic protein signalling pathway by inhibiting SMAD6 in a mouse model of femoral fracture: An animal study.","date":"2019","source":"Bone & joint research","url":"https://pubmed.ncbi.nlm.nih.gov/31832175","citation_count":16,"is_preprint":false},{"pmid":"24446200","id":"PMC_24446200","title":"Smad6 suppresses the growth and self-renewal of hepatic progenitor cells.","date":"2014","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24446200","citation_count":16,"is_preprint":false},{"pmid":"29620201","id":"PMC_29620201","title":"MicroRNA‑92a overexpression promotes the osteogenic differentiation of bone mesenchymal stem cells by impeding Smad6‑mediated runt‑related transcription factor 2 degradation.","date":"2018","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/29620201","citation_count":16,"is_preprint":false},{"pmid":"31992960","id":"PMC_31992960","title":"SMAD6, positively regulated by the DNM3OS-miR-134-5p axis, confers promoting effects to cell proliferation, migration and EMT process in retinoblastoma.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/31992960","citation_count":16,"is_preprint":false},{"pmid":"11408948","id":"PMC_11408948","title":"Mutational analysis of the Smad6 and Smad7 genes in hepatocellular carcinoma.","date":"2001","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11408948","citation_count":16,"is_preprint":false},{"pmid":"25762727","id":"PMC_25762727","title":"Arkadia enhances BMP signalling through ubiquitylation and degradation of Smad6.","date":"2015","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25762727","citation_count":15,"is_preprint":false},{"pmid":"30848080","id":"PMC_30848080","title":"A novel SMAD6 variant in a patient with severely calcified bicuspid aortic valve and thoracic aortic aneurysm.","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30848080","citation_count":15,"is_preprint":false},{"pmid":"20016939","id":"PMC_20016939","title":"Hoxc8 represses BMP-induced expression of Smad6.","date":"2009","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/20016939","citation_count":14,"is_preprint":false},{"pmid":"16687405","id":"PMC_16687405","title":"Smad6 represses Dlx3 transcriptional activity through inhibition of DNA binding.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16687405","citation_count":14,"is_preprint":false},{"pmid":"30963242","id":"PMC_30963242","title":"Biallelic variants in SMAD6 are associated with a complex cardiovascular phenotype.","date":"2019","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30963242","citation_count":14,"is_preprint":false},{"pmid":"33892661","id":"PMC_33892661","title":"A high level of lncFGD5-AS1 inhibits epithelial-to-Mesenchymal transition by regulating the miR-196a-5p/SMAD6/BMP axis in gastric Cancer.","date":"2021","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33892661","citation_count":14,"is_preprint":false},{"pmid":"11078792","id":"PMC_11078792","title":"Mutation analysis of the Smad6 and Smad7 gene in human ovarian cancers.","date":"2000","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/11078792","citation_count":14,"is_preprint":false},{"pmid":"15665522","id":"PMC_15665522","title":"Adrenomedullin impairs the profibrotic effects of transforming growth factor-beta1 through recruiting Smad6 protein in human renal tubular cells.","date":"2005","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15665522","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51364,"output_tokens":7720,"usd":0.134946},"stage2":{"model":"claude-opus-4-6","input_tokens":11518,"output_tokens":4852,"usd":0.268335},"total_usd":0.403281,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"Smad6 forms stable associations with TGF-β superfamily type I receptors, interferes with phosphorylation of Smad2 by the TGF-β type I receptor, blocks subsequent Smad2-Smad4 heteromerization, and inhibits phosphorylation of Smad1 induced by the BMP type IB receptor, acting as an inhibitory Smad.\",\n      \"method\": \"Co-immunoprecipitation, phosphorylation assays, transfection-based signaling assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational paper with multiple orthogonal methods, >874 citations, replicated by subsequent studies\",\n      \"pmids\": [\"9335505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Smad6 specifically competes with Smad4 for binding to receptor-activated (phosphorylated) Smad1, yielding an apparently inactive Smad1-Smad6 complex, thereby acting as a Smad4 decoy to selectively antagonize BMP/Smad1 signaling without interfering with receptor-mediated phosphorylation of Smad1.\",\n      \"method\": \"Co-immunoprecipitation, Xenopus embryo overexpression assays, mammalian cell transfection, transcriptional reporter assays\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods in two model systems, >579 citations, replicated across labs\",\n      \"pmids\": [\"9436979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Smad6 selectively inhibits BMP signaling from the ALK-3/6 subgroup of BMP type I receptors in preference to the ALK-1/2 subgroup; specific amino acid residues (Arg-238, Phe-264, Thr-265, Ala-269) in the N-terminal lobe of the ALK-3 kinase domain determine Smad6 sensitivity, and direct interaction with type I receptors is a critical step in Smad6 function.\",\n      \"method\": \"Transcriptional reporter assays, mutagenesis of receptor residues, co-immunoprecipitation\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis combined with binding and functional assays in multiple cell types\",\n      \"pmids\": [\"17493940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Smad6 interacts with the homeobox transcription factor Hoxc-8 as a transcriptional corepressor in the nucleus; the Smad6-Hoxc-8 heterodimer binds DNA (including Hoxa-9 sites) and inhibits Smad1 interaction with Hoxc-8 and Smad1-induced transcriptional activity, providing a nuclear mechanism of BMP signal inhibition.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, gel-shift (EMSA) assays, luciferase reporter assays\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (Y2H, Co-IP, EMSA, reporter), strong mechanistic follow-up\",\n      \"pmids\": [\"10722652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Smad6 knockout mice display cardiac valve hyperplasia, outflow tract septation defects, aortic ossification, and elevated blood pressure, demonstrating an essential in vivo role for Smad6 in cardiovascular development and homeostasis through modulation of TGF-β superfamily signaling.\",\n      \"method\": \"Targeted gene disruption (knockout mouse), LacZ reporter knock-in for expression mapping, histological and physiological analyses\",\n      \"journal\": \"Nature Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean in vivo KO with specific cardiovascular phenotypic readouts, >388 citations\",\n      \"pmids\": [\"10655064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"BMP2-induced apoptosis is mediated through activation of TAK1 and subsequent p38 phosphorylation; Smad6 blocks this pathway by directly binding to TAK1, preventing TAK1 activation and p38 phosphorylation, demonstrating a non-Smad inhibitory mechanism.\",\n      \"method\": \"Kinase-negative TAK1 expression, co-immunoprecipitation of Smad6-TAK1, apoptosis assays, Western blot for p38 phosphorylation\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding shown by Co-IP, functional rescue with kinase-dead TAK1, multiple readouts\",\n      \"pmids\": [\"10748100\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The mouse Smad6 promoter contains a proximal BMP-responsive element (PBE) with a GC-rich GCCGnCGC-like motif that is directly bound by BMP-activated Smad1/5 and Smad4, driving Smad6 transcription as a negative feedback loop.\",\n      \"method\": \"Promoter deletion analysis, luciferase reporter assays, gel-shift (EMSA) for direct DNA binding by Smad1/5 and Smad4\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct DNA binding demonstrated by EMSA plus functional promoter dissection\",\n      \"pmids\": [\"10692396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Smad6 recruits transcriptional corepressor CtBP via a consensus PLDLS motif in its linker region to repress BMP-induced Id1 transcription; mutation of the PLDLS motif abolishes CtBP binding and the repressor activity of Smad6.\",\n      \"method\": \"Co-immunoprecipitation, mutagenesis of the PLDLS motif, luciferase reporter assays\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis combined with binding assays and transcriptional readout\",\n      \"pmids\": [\"14645520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Smad6 interacts with Runx2 (but not Smad7) and mediates Smurf1-induced ubiquitin-proteasome-dependent degradation of Runx2, serving as a scaffold between Smurf1 and Runx2 in a Smad6-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitin-proteasome degradation assays with proteasome inhibitors, deletion mutant analysis\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus functional ubiquitination/degradation assays with mechanistic controls\",\n      \"pmids\": [\"16299379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Smad6 interacts with the N-terminal domain of the glucocorticoid receptor (GR) through its MH2 domain and suppresses GR-mediated transcriptional activity by recruiting histone deacetylase 3 (HDAC3) to DNA-bound GR, antagonizing histone H3/H4 acetylation induced by p160 coactivators.\",\n      \"method\": \"Co-immunoprecipitation, adenovirus-mediated overexpression in vivo (rat liver), chromatin acetylation assays, luciferase reporter assays\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods including in vivo delivery and mechanistic dissection of HDAC3 recruitment\",\n      \"pmids\": [\"16249187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Smad6 binds to Pellino-1 (an adaptor protein of IRAK1) via its MH2 domain, abrogating IRAK1-Pellino-1-TRAF6 complex formation after IL-1β stimulation, thereby preventing IκBα degradation, NF-κB nuclear translocation, and pro-inflammatory gene expression as part of TGF-β/BMP anti-inflammatory signaling.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, NF-κB reporter assays, gene expression analysis\",\n      \"journal\": \"Nature Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding shown, functional rescue by knockdown, mechanistic pathway placement with multiple readouts\",\n      \"pmids\": [\"16951688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Smad6 is phosphorylated at a serine residue by protein kinase X (PrKX); during macrophage differentiation of HL-60 cells, Smad6 co-localizes with PrKX in the nucleus and shows increased serine phosphorylation, correlating with increased Smad6 binding to osteopontin, Id2, and Hex gene promoters.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, in vitro phosphorylation assay, mutagenesis, EMSA, chromatin immunoprecipitation (ChIP), siRNA knockdown\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay with mutagenesis, ChIP, and functional differentiation readout\",\n      \"pmids\": [\"16491121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PRMT1 methylates Smad6 (and Smad7) but not R-Smads or Smad4; PRMT1 interacts with the N-terminal domain of Smad6 and dimethylates Arg74 in mouse Smad6 as identified by mass spectrometry.\",\n      \"method\": \"In vitro methylation assay, mass spectrometry, co-immunoprecipitation, mutagenesis (Smad6-R74A)\",\n      \"journal\": \"FEBS Letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of methylation, mass-spectrometric identification of modified residue, domain mapping\",\n      \"pmids\": [\"17118358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Smad6 directly interacts with Tbx6 through its MH2 domain (binding residues 90-180 of Tbx6) and recruits Smurf1 to facilitate ubiquitin-proteasome-dependent degradation of Tbx6, thereby reducing Tbx6-mediated Myf-5 gene activation.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, ubiquitination/degradation assays, siRNA knockdown, reporter assays\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding with domain mapping, functional ubiquitination assay, and gene expression readout\",\n      \"pmids\": [\"19561075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TGF-β1-induced Smad6 (but not Smad7) recruits Smurf1 and Smurf2 E3 ubiquitin ligases to mediate K48-linked polyubiquitination and proteasomal degradation of the TLR adaptor MyD88, thereby inhibiting MyD88-dependent pro-inflammatory NF-κB signaling.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitin linkage assays, siRNA knockdown, NF-κB reporter assays, gene expression analysis\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic dissection of K48 ubiquitin linkage, Smad6-specificity vs Smad7, Smurf1/2 dependence by siRNA\",\n      \"pmids\": [\"21897371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Smad6 promotes neuronal differentiation in the intermediate zone of the chick dorsal spinal cord by inhibiting both BMP signaling and the Wnt/β-catenin pathway; the inhibition of Wnt/β-catenin is independent of BMP inhibition and is mediated through the N-terminal domain and linker region of Smad6, which enhances CtBP interaction with the β-catenin/TCF complex.\",\n      \"method\": \"In ovo knockdown experiments (chick), reporter assays, co-immunoprecipitation, domain deletion analysis\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo knockdown with defined phenotype plus mechanistic dissection by domain mutants and Co-IP\",\n      \"pmids\": [\"21730158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Smad6 (but not Smad7) negatively regulates the noncanonical TGF-β1-TRAF6-TAK1-p38 MAPK/JNK pathway by recruiting the deubiquitinase A20 to TRAF6, removing K63-linked polyubiquitin chains from TRAF6 and preventing TAK1 activation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitin linkage assays, siRNA knockdown in cells and in vivo animal models, MAPK phosphorylation assays\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct A20-Smad6-TRAF6 complex shown, K63 deubiquitination mechanism, validated in vivo\",\n      \"pmids\": [\"24096742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"UBE2O (E2-230K) functions as an E2-E3 hybrid enzyme that monoubiquitinates SMAD6 at lysine 174; monoubiquitinated SMAD6 has impaired binding to the BMP type I receptor, reducing its inhibitory activity toward BMP7 signaling, and this modification promotes BMP7-induced adipogenesis.\",\n      \"method\": \"Proteomic interaction screen, in vitro ubiquitination assay, mutagenesis (Lys174 and Cys885 of UBE2O), co-immunoprecipitation, BMP signaling reporter assays, adipogenesis assays\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro ubiquitination reconstitution, site-specific mutagenesis, functional consequence on receptor binding and signaling\",\n      \"pmids\": [\"23455153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Arkadia (an E3 ubiquitin ligase) induces ubiquitylation and proteasome-dependent degradation of Smad6 (in addition to Smad7 and c-Ski/SnoN); wild-type Arkadia but not the catalytically inactive C937A mutant causes Smad6 degradation, thereby enhancing BMP-induced osteoblast differentiation.\",\n      \"method\": \"Ubiquitylation assay, proteasome inhibitor treatment, Arkadia knockdown/KO MEFs, luciferase reporter assays, mutagenesis\",\n      \"journal\": \"Journal of Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro ubiquitylation, catalytic mutant control, KO cell validation\",\n      \"pmids\": [\"25762727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Nuclear Smad6 directly interacts with PIAS3 through its MH2 domain, recruits Smurf1 (via Smad6's MH2 domain and PY motif) to promote PIAS3 ubiquitination and degradation, thereby reducing PIAS3-mediated STAT3 inhibition and enhancing STAT3-driven glioma cell growth.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, ubiquitination assays, siRNA knockdown, cell growth and stem-cell initiation assays\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding with domain mapping, mechanistic ubiquitination assay, functional tumor cell readout\",\n      \"pmids\": [\"29950561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PRMT1-induced arginine methylation of Smad6 enables Smad6 to recruit MyD88 and promote its degradation, thereby inhibiting TLR-NF-κB signaling; disruption of Smad6 methylation exacerbates inflammation and bone loss in experimental periodontitis.\",\n      \"method\": \"Co-immunoprecipitation, in vitro methylation assay, siRNA knockdown, NF-κB reporter assays, in vivo periodontitis model\",\n      \"journal\": \"Journal of Dental Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — methylation-dependent mechanism with in vitro and in vivo validation, functional consequence\",\n      \"pmids\": [\"29420098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SMAD6 functions downstream of ligand-induced Notch1 signaling and upstream of the vascular protocadherin PCDH12 to transduce endothelial cell flow-mediated responses; loss of SMAD6 in endothelial cells causes defective barrier function, upregulation of proliferation-associated genes, downregulation of junction genes, and impaired flow-mediated alignment.\",\n      \"method\": \"siRNA knockdown, endothelial cell flow assays, genetic rescue with full-length SMAD6, gene expression analysis, Notch1 pathway manipulation\",\n      \"journal\": \"Angiogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis established by concomitant Notch1/SMAD6 manipulation, PCDH12 placed downstream, specific functional readouts\",\n      \"pmids\": [\"33779885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Loss of Smad6 in mice leads to skeletal defects including posterior vertebral transformation, bilateral ossification centers, bifid sternebrae, and an expanded hypertrophic zone in growth plates due to increased BMP responsiveness in Smad6-deficient chondrocytes, establishing Smad6 as an essential intracellular limiter of BMP signaling during endochondral bone formation.\",\n      \"method\": \"Smad6 knockout mouse, histological analysis, BMP responsiveness assays in isolated chondrocytes\",\n      \"journal\": \"Journal of Bone and Mineral Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined skeletal phenotypes and BMP responsiveness assay in isolated cells\",\n      \"pmids\": [\"21681813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"JNK1 activation decreases binding of inhibitory Smad6 to the type I BMP receptor (BMPR-I) and reciprocally increases binding of Smad1 to BMPR-I, thereby increasing cellular responsiveness to BMP-2 and promoting osteoblast differentiation.\",\n      \"method\": \"JNK gain- and loss-of-function, co-immunoprecipitation of Smad6/Smad1 with BMPR-I, osteoblast differentiation and mineralization assays\",\n      \"journal\": \"Journal of Bone and Mineral Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct receptor binding assay, functional differentiation readout, single lab\",\n      \"pmids\": [\"21542012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Runx1 directly regulates Smad6 expression in the aorta-gonad-mesonephros region via a novel upstream enhancer (with Fli1, Gata2, and Scl), establishing a rheostat in which Runx1 drives its own negative control through Smad6-mediated proteasomal targeting of Runx1.\",\n      \"method\": \"ChIP in AGM region, Runx1 KO embryo analysis, proteasome inhibitor experiments, enhancer reporter assays\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP in vivo, KO embryo, functional enhancer validation, epistasis established\",\n      \"pmids\": [\"21576367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Smad6 inhibits the Wnt/β-catenin pathway in hepatic progenitor cells by promoting CtBP interaction with the β-catenin/TCF complex to inhibit β-catenin-mediated transcriptional activation, suppressing HPC proliferation and self-renewal.\",\n      \"method\": \"Ectopic expression, siRNA knockdown of β-catenin, co-immunoprecipitation, reporter assays, proliferation assays\",\n      \"journal\": \"Journal of Cellular Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, mechanistic Co-IP and reporter, but limited orthogonal validation\",\n      \"pmids\": [\"24446200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BMP-2 activates Smad6 gene transcription via a bone-specific OSE2-a element in the Smad6 promoter through the combined action of Runx2 and BMP-activated Smad1; Smad1 excludes Smurf1 from the OSE2 site, promoting Smad6 transcription, while Smurf1 inhibits it.\",\n      \"method\": \"Promoter deletion/mutation analysis, luciferase reporter assays, EMSA, ChIP assays\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct DNA binding shown by EMSA and ChIP, mutagenesis of OSE2-a site\",\n      \"pmids\": [\"17215250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Smad6 interacts with Dlx3 (via residues 80-163 of Dlx3 including part of the homeodomain) and Dlx4 homeobox transcription factors in the nucleus of trophoblasts, inhibiting Dlx3 binding to specific target gene promoter sites and repressing Dlx3-dependent transcription.\",\n      \"method\": \"Co-immunoprecipitation, immunocytochemistry, in vitro protein interaction with deletion mutants, EMSA, luciferase reporter assays, siRNA knockdown\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, domain mapping, functional reporter and siRNA confirmation\",\n      \"pmids\": [\"16687405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Notch signaling sets endothelial cell BMP responsiveness by regulating SMAD6 expression upstream of BMP target gene transcription; SMAD6 acts as a cell-intrinsic BMP inhibitor downstream of Notch, controlling lateral vessel branching in response to pro-angiogenic BMP2 and BMP6 ligands.\",\n      \"method\": \"Zebrafish in vivo model, endothelial cell in vitro BMP assays, Notch pathway manipulation, SMAD6 overexpression/knockdown\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro validation, genetic epistasis (Notch→SMAD6→BMP response), multiple readouts\",\n      \"pmids\": [\"27834400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"AMPK activation upregulates Smad6 and Smurf1 and enhances their interaction, leading to proteasome-dependent degradation of ALK2 (including the FOP-associated ALK2-R206H mutant); knockdown of either Smad6 or Smurf1 prevents metformin-induced ALK2 reduction.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown of Smad6/Smurf1, proteasome inhibitor assays, AMPK gain/loss-of-function, FOP patient-derived iPS cells\",\n      \"journal\": \"Biochimica et Biophysica Acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic Co-IP, siRNA epistasis, proteasome inhibitor validation, patient-derived cells\",\n      \"pmids\": [\"28847510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SMAD6 loss in murine development causes vessel hemorrhage associated with increased VE-cadherin endocytosis, disrupted endothelial adherens junctions, increased vessel branching and sprouting in postnatal retinal vessels, placing SMAD6 as essential for vascular junction stabilization.\",\n      \"method\": \"Conditional/global SMAD6 KO mice, retinal vessel imaging, endothelial cell junction analysis, VE-cadherin endocytosis assay, siRNA knockdown in vitro\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with specific vascular phenotype, mechanistic in vitro follow-up on junctions\",\n      \"pmids\": [\"30098998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Smad6 and Smad7 inhibit BMP2-induced neurite outgrowth in PC12 cells by interacting physically with TAK1-binding protein (TAB1), a molecule required for TAK1 activation, thereby blocking the TAK1-p38 kinase pathway.\",\n      \"method\": \"Co-immunoprecipitation of Smad6/7 with TAB1, kinase-negative TAK1 expression, neurite outgrowth assay, p38 phosphorylation assay\",\n      \"journal\": \"Genes to Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding to TAB1 shown by Co-IP, functional kinase-dead rescue, single lab\",\n      \"pmids\": [\"11737269\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SMAD6 is an inhibitory SMAD that negatively regulates BMP/TGF-β superfamily signaling through multiple mechanisms: (1) it binds stably to BMP type I receptors (preferentially ALK-3/6) to block receptor-regulated SMAD phosphorylation; (2) it acts as a Smad4 decoy by competing with Smad4 for binding to phosphorylated Smad1, forming an inactive Smad1-Smad6 complex; (3) in the nucleus it recruits corepressors CtBP and HDAC3 to repress BMP target gene transcription and acts as a corepressor with Hox transcription factors; (4) it blocks non-canonical signaling by binding TAK1 or recruiting the deubiquitinase A20 to TRAF6 to remove K63-linked polyubiquitin; (5) it scaffolds Smurf1/Smurf2 E3 ligases to mediate degradation of substrates including Runx2, Tbx6, PIAS3, and MyD88; (6) it is itself post-translationally regulated by UBE2O-mediated monoubiquitination at Lys174 (reducing receptor binding), PRMT1-mediated arginine methylation at Arg74, PrKX-mediated serine phosphorylation, and Arkadia-mediated ubiquitylation/degradation; and (7) its expression is transcriptionally induced by BMP-activated Smad1/5-Smad4 complexes binding a GC-rich element in its promoter, establishing a negative feedback loop essential for cardiovascular, skeletal, and hematopoietic development.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SMAD6 is an inhibitory SMAD that serves as a central negative regulator of BMP/TGF-β superfamily signaling and inflammatory pathways through multiple cytoplasmic and nuclear mechanisms. In the cytoplasm, SMAD6 binds preferentially to BMP type I receptors ALK-3/6 to block R-SMAD phosphorylation, acts as a SMAD4 decoy by forming inactive complexes with phosphorylated SMAD1, inhibits non-canonical TAK1-p38 signaling by binding TAK1 and recruiting deubiquitinase A20 to TRAF6, and scaffolds Smurf1/Smurf2 E3 ligases to target substrates including Runx2, Tbx6, MyD88, PIAS3, and ALK2 for proteasomal degradation [PMID:9335505, PMID:9436979, PMID:10748100, PMID:24096742, PMID:16299379, PMID:21897371, PMID:29950561]. In the nucleus, SMAD6 recruits corepressors CtBP and HDAC3 to repress BMP target genes and glucocorticoid receptor targets, acts as a corepressor with Hox and Dlx transcription factors, and inhibits Wnt/β-catenin signaling by promoting CtBP interaction with the β-catenin/TCF complex [PMID:14645520, PMID:16249187, PMID:10722652, PMID:21730158]. SMAD6 itself is regulated post-translationally by UBE2O-mediated monoubiquitination at Lys174, PRMT1 methylation at Arg74, PrKX phosphorylation, Arkadia-mediated degradation, and JNK1-dependent modulation of receptor binding, while its transcription is driven by BMP-activated SMAD1/5-SMAD4 through a GC-rich promoter element and by Runx2 through a bone-specific OSE2-a element, establishing tissue-specific negative feedback loops essential for cardiovascular, skeletal, vascular, and hematopoietic development [PMID:23455153, PMID:17118358, PMID:16491121, PMID:25762727, PMID:10692396, PMID:17215250, PMID:10655064, PMID:21681813, PMID:30098998].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Identification of SMAD6 as an inhibitory SMAD that stably associates with TGF-β/BMP type I receptors and blocks R-SMAD phosphorylation established the existence of intracellular antagonists within the SMAD signaling cascade.\",\n      \"evidence\": \"Co-immunoprecipitation and phosphorylation assays in transfected mammalian cells\",\n      \"pmids\": [\"9335505\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor subtype specificity not yet defined\", \"Nuclear versus cytoplasmic site of action unclear\", \"Post-translational regulation of SMAD6 unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstration that SMAD6 acts as a SMAD4 decoy — competing with SMAD4 for binding to phosphorylated SMAD1 to form an inactive complex — revealed a second inhibitory mechanism independent of receptor blockade and explained SMAD6's preference for BMP over TGF-β signaling.\",\n      \"evidence\": \"Co-immunoprecipitation in mammalian cells and functional assays in Xenopus embryos\",\n      \"pmids\": [\"9436979\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SMAD6 employs both mechanisms simultaneously in physiological contexts not resolved\", \"Structural basis of SMAD1-SMAD6 versus SMAD1-SMAD4 competition unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Four simultaneous discoveries in 2000 defined the physiological importance and mechanistic breadth of SMAD6: knockout mice revealed essential cardiovascular roles; SMAD6 was shown to block non-canonical BMP-TAK1-p38 signaling by binding TAK1; nuclear corepressor function was established through interaction with Hoxc-8; and BMP-responsive promoter elements were identified, closing the negative feedback loop.\",\n      \"evidence\": \"Smad6 KO mice with cardiac valve/outflow tract defects; Co-IP of SMAD6-TAK1 with kinase-dead rescue; yeast two-hybrid and EMSA for SMAD6-Hoxc-8 DNA binding; promoter deletion and EMSA for SMAD1/5-SMAD4 binding to GCCGnCGC element\",\n      \"pmids\": [\"10655064\", \"10748100\", \"10722652\", \"10692396\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"TAK1 binding mechanism and whether it involves TAB1 or is direct not fully resolved\", \"Relative contribution of receptor-level versus nuclear inhibition in vivo unclear\", \"Feedback loop dynamics not quantified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of CtBP as a SMAD6-recruited corepressor via a PLDLS motif in the linker region established the molecular basis of SMAD6's transcriptional repressor activity at BMP target genes such as Id1.\",\n      \"evidence\": \"Co-IP and mutagenesis of PLDLS motif with BMP-responsive reporter assays\",\n      \"pmids\": [\"14645520\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide targets of SMAD6-CtBP repression not defined\", \"Whether CtBP and HDAC3 corepressor activities are independent or cooperative unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Discovery that SMAD6 scaffolds the Smurf1 E3 ligase to Runx2 for ubiquitin-proteasomal degradation, and independently recruits HDAC3 to suppress glucocorticoid receptor transcription, revealed SMAD6 as a versatile adaptor for both protein degradation and chromatin modification beyond canonical SMAD pathways.\",\n      \"evidence\": \"Reciprocal Co-IP of SMAD6-Runx2-Smurf1 with proteasome inhibitor controls; Co-IP of SMAD6-GR-HDAC3 with chromatin acetylation assays and in vivo adenoviral delivery\",\n      \"pmids\": [\"16299379\", \"16249187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full repertoire of SMAD6-Smurf substrates not catalogued\", \"Whether SMAD6-HDAC3 interaction is direct or bridged unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Multiple 2006 studies expanded SMAD6's regulatory network: post-translational modifications by PrKX (serine phosphorylation) and PRMT1 (Arg74 methylation) were mapped; anti-inflammatory function through disruption of the IRAK1-Pellino-1-TRAF6 complex was demonstrated; Notch-driven SMAD6 expression was shown to set BMP responsiveness; and nuclear interactions with Dlx3/4 homeodomain factors in trophoblasts were established.\",\n      \"evidence\": \"In vitro kinase and methylation assays with mass spectrometry and mutagenesis; Co-IP of SMAD6-Pellino-1 with NF-κB reporter and siRNA; SMAD6 interaction with Dlx3 by Co-IP, EMSA, and siRNA\",\n      \"pmids\": [\"16491121\", \"17118358\", \"16951688\", \"16687405\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of Arg74 methylation on SMAD6 activity not fully characterized in this year\", \"Cross-talk between phosphorylation and methylation modifications unknown\", \"Whether Pellino-1 binding and Smurf scaffolding are mutually exclusive unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Receptor subtype specificity of SMAD6 was resolved: SMAD6 preferentially inhibits ALK-3/6 over ALK-1/2, with specific kinase domain residues (Arg-238, Phe-264, Thr-265, Ala-269) determining sensitivity; additionally, Runx2-dependent bone-specific Smad6 transcription through an OSE2-a promoter element was identified.\",\n      \"evidence\": \"Mutagenesis of ALK-3 kinase domain residues with Co-IP and reporter assays; promoter deletion, EMSA, and ChIP for OSE2-a element\",\n      \"pmids\": [\"17493940\", \"17215250\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of SMAD6-ALK3 kinase domain interaction not determined\", \"Whether ALK-1/2 escape from SMAD6 inhibition is physiologically important in specific tissues unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Extension of the SMAD6-Smurf scaffolding paradigm to Tbx6 degradation showed SMAD6's MH2 domain bridges Smurf1 to diverse transcription factor substrates, establishing a generalizable adaptor mechanism.\",\n      \"evidence\": \"Co-IP with domain mapping, ubiquitination and degradation assays, siRNA knockdown, and Myf-5 reporter readout\",\n      \"pmids\": [\"19561075\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SMAD6-Smurf targets other T-box family members not tested\", \"In vivo significance for somitogenesis not demonstrated\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"A cluster of 2011 studies defined SMAD6's roles in innate immunity, Wnt inhibition, skeletal development, and hematopoietic feedback: SMAD6 recruits Smurf1/2 for K48-linked ubiquitination and degradation of MyD88; SMAD6 inhibits Wnt/β-catenin signaling by enhancing CtBP-β-catenin/TCF interaction during neural differentiation; Smad6 KO mice exhibit vertebral and growth plate defects from excess BMP signaling; JNK1 reduces SMAD6-receptor binding to enhance BMP responsiveness; and Runx1 drives Smad6 expression to create a self-limiting hematopoietic feedback loop.\",\n      \"evidence\": \"Co-IP with ubiquitin linkage assays and NF-κB reporters; in ovo knockdown in chick with domain deletion analysis; Smad6 KO mouse skeletal phenotyping with chondrocyte BMP assays; JNK gain/loss-of-function with receptor Co-IP; ChIP in AGM region with Runx1 KO embryos\",\n      \"pmids\": [\"21897371\", \"21730158\", \"21681813\", \"21542012\", \"21576367\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SMAD6-mediated Wnt inhibition operates beyond neural and hepatic contexts not established\", \"Mechanism by which JNK1 displaces SMAD6 from receptors not molecularly defined\", \"Relative contributions of Smurf1 versus Smurf2 to MyD88 degradation not resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Two key regulatory mechanisms were uncovered: SMAD6 recruits deubiquitinase A20 to remove K63-polyubiquitin from TRAF6, blocking non-canonical TGF-β1-TAK1 signaling; and UBE2O monoubiquitinates SMAD6 at Lys174, impairing receptor binding and thereby relieving SMAD6's inhibition of BMP7 signaling to promote adipogenesis.\",\n      \"evidence\": \"Co-IP of A20-SMAD6-TRAF6 with K63 deubiquitination assays and in vivo validation; in vitro ubiquitination reconstitution with Lys174 mutagenesis, receptor binding assays, and adipogenesis readout\",\n      \"pmids\": [\"24096742\", \"23455153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether A20 recruitment and Smurf scaffolding occur on the same or different SMAD6 pools unknown\", \"Other monoubiquitination sites on SMAD6 not surveyed\", \"Tissue-specific regulation of UBE2O-SMAD6 axis not explored\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Arkadia (RNF111) was identified as an E3 ligase that ubiquitinates and degrades SMAD6 via the proteasome, providing a mechanism for relieving SMAD6-imposed BMP inhibition during osteoblast differentiation.\",\n      \"evidence\": \"Ubiquitylation assay with catalytic mutant C937A, proteasome inhibitor treatment, Arkadia KO MEFs, BMP reporter assays\",\n      \"pmids\": [\"25762727\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Arkadia targets SMAD6 in non-bone contexts unknown\", \"Lysine residues on SMAD6 targeted by Arkadia not mapped\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"AMPK activation was shown to upregulate both SMAD6 and Smurf1 and enhance their interaction, leading to degradation of the BMP type I receptor ALK2, including the disease-associated ALK2-R206H FOP mutant — revealing a pharmacologically targetable SMAD6-dependent receptor turnover pathway.\",\n      \"evidence\": \"Co-IP and siRNA epistasis for SMAD6-Smurf1-ALK2, proteasome inhibitor validation, FOP patient-derived iPSCs\",\n      \"pmids\": [\"28847510\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SMAD6-Smurf1 targets other type I receptors beyond ALK2 via AMPK not tested\", \"In vivo therapeutic efficacy not demonstrated\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Three 2018 studies revealed new dimensions of SMAD6 function: PRMT1-mediated methylation enables SMAD6 to recruit and degrade MyD88, limiting inflammation and bone loss; nuclear SMAD6 scaffolds Smurf1 to degrade the STAT3 inhibitor PIAS3, promoting glioma growth; and SMAD6 loss causes vascular hemorrhage through increased VE-cadherin endocytosis and disrupted adherens junctions.\",\n      \"evidence\": \"In vitro methylation with in vivo periodontitis model; Co-IP and domain mapping of SMAD6-PIAS3-Smurf1 with glioma cell growth assays; conditional/global SMAD6 KO mice with retinal vessel imaging and VE-cadherin endocytosis assay\",\n      \"pmids\": [\"29420098\", \"29950561\", \"30098998\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SMAD6-PIAS3 axis operates in tumors beyond glioma not tested\", \"Direct mechanism linking SMAD6 loss to VE-cadherin endocytosis not molecularly defined\", \"Methylation-dependent substrate selection by SMAD6 not systematically addressed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"SMAD6 was placed in a Notch1→SMAD6→PCDH12 signaling axis in endothelial cells that controls flow-mediated responses, barrier function, and junctional gene expression, extending SMAD6's vascular roles beyond BMP inhibition.\",\n      \"evidence\": \"siRNA knockdown and genetic rescue in endothelial cells under flow, epistasis with Notch1 pathway manipulation, gene expression profiling\",\n      \"pmids\": [\"33779885\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SMAD6's role in flow sensing requires its BMP-inhibitory or scaffolding activities unknown\", \"Mechanism by which SMAD6 regulates PCDH12 expression not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include the structural basis of SMAD6's selective interaction with ALK-3/6, how multiple post-translational modifications (ubiquitination, methylation, phosphorylation) are integrated to regulate SMAD6 activity in specific cellular contexts, and whether SMAD6's diverse scaffolding, corepressor, and decoy functions are partitioned by subcellular localization or by distinct SMAD6 pools.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal structure of SMAD6 in complex with any receptor or partner\", \"Systematic identification of all SMAD6-Smurf substrates lacking\", \"Integration of multiple PTMs on a single SMAD6 molecule not studied\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [8, 13, 14, 19, 29]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 2, 5, 16]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [3, 7, 9, 27]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 7, 9, 11, 19, 27]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1, 2, 5, 10, 16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 2, 5, 6, 15, 16, 28]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4, 22, 30]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10, 14, 20]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [8, 13, 14, 17, 18, 19]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [3, 7, 9, 27]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"SMURF1\",\n      \"SMURF2\",\n      \"SMAD1\",\n      \"MAP3K7\",\n      \"TNFAIP3\",\n      \"TRAF6\",\n      \"CTBP1\",\n      \"UBE2O\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}